Discount Code (0% Off) has been applied.
 
Enter a search term.

If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.

1 (800) 854-7220
answers@mcguff.com Suggest an Item
Manufacturer: Hospira

..

000719
000719
Manufacturer: Hospira (Shop the Brand)

Lidocaine HCl 2%and Epinephrine Injection 20 mg/mL, Fliptop Multiple Dose Vial 30 mL, Each

Item Code: 000719
Mfg Part #: 0409-3182-02
$12.99
Requires Verified Medical License to Purchase
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
About This Product

..

Products specifications
Medical License Required Yes
Class Rx Only
Product Name Injection
Generic Name Lidocaine HCl and Epinephrine
Route of Administration Infiltration, Nerve Block
Strength 20 mg/mL
Volume 30 mL
Container Fliptop Multiple Dose Vial
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Local anesthesia

Lidocaine Hydrochloride and Epinephrine Injection

Lidocaine Hydrochloride and Epinephrine Injection is a sterile combination of lidocaine, an amide-type local anesthetic, and epinephrine, an alpha and beta adrenergic agonist. Indicated for adult and pediatric patients, it delivers local or regional anesthesia and analgesia across surgical, dental, diagnostic, therapeutic, and obstetrical procedures.

Key Benefits

  • Broad Procedural Coverage: Indicated for infiltration, peripheral nerve blocks, sympathetic nerve blocks, epidural, and caudal anesthesia.
  • Multiple Concentrations and Presentations: Available in 0.5%, 1%, 1.5%, and 2% concentrations in single-dose ampuls, single-dose vials, and multiple-dose vials.
  • Higher Maximum Dose with Epinephrine: The combination allows up to 7 mg/kg (not to exceed 500 mg), versus 4.5 mg/kg (not to exceed 300 mg) for lidocaine alone.
  • Pediatric and Adult Approved: Indicated across a wide range of procedures in both adult and pediatric patients.
  • Epidural Test Dose Capability: The 1.5% concentration with 1:200,000 epinephrine is specifically recommended as a test dose for epidural and caudal blocks to detect unintended intravascular or intrathecal injection.

Dosage and Administration

Dosage is individualized based on the anesthetic procedure, tissue vascularity, required anesthesia depth, and patient condition. Always use the lowest effective concentration and smallest dose producing the desired result.

  • Adult Maximum Dose: Not to exceed 7 mg/kg body weight or 500 mg total.
  • Continuous Epidural/Caudal Anesthesia: Maximum dose intervals must not be less than 90 minutes.
  • Pediatric Dosing (over 3 years): Approximately 3.3 mg/kg to 4.4 mg/kg, adjusted for weight and development.

Why Choose Lidocaine Hydrochloride and Epinephrine Injection?

This combination product delivers local anesthetic action via lidocaine and vasoconstrictive support via epinephrine in a single formulation, supporting infiltration, nerve block, epidural, and caudal block types across multiple concentrations and vial presentations — as described in the prescribing information.

Warnings

  • Dose-Related Toxicity: Cardiovascular and respiratory vital signs and patient consciousness must be monitored after each injection; delays in managing toxicity may lead to acidosis, cardiac arrest, and death.
  • Methemoglobinemia: Cases have been reported with local anesthetic use; patients with G6PD deficiency, infants under 6 months, and those on oxidizing agents are at increased risk of severe outcomes including seizures, arrhythmias, and death.
  • Systemic Toxicity Risk from Unintended Injection: Unintended intravascular or intrathecal injection may cause CNS or cardiorespiratory depression, coma, and respiratory arrest; aspirate prior to each injection and use a test dose for epidural blocks when feasible.

Disclaimer: This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.
Products specifications
Lidocaine HCl 2and Epinephrine Injection 20 mgmL Fliptop Multiple Dose Vial 30 mL 25Tray
000719
Picture of Lidocaine HCl 2%and Epinephrine Injection 20 mg/mL, Fliptop Multiple Dose Vial 30 mL, 25/Tray
Manufacturer: Hospira (Shop the Brand)

Lidocaine HCl 2%and Epinephrine Injection 20 mg/mL, Fliptop Multiple Dose Vial 30 mL, 25/Tray

Item Code: 009514
Mfg Part #: 0409-3182-02
$292.28
Requires Verified Medical License to Purchase
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
About This Product

..

Products specifications
Medical License Required Yes
Class Rx Only
Product Name Injection
Generic Name Lidocaine HCl and Epinephrine
Route of Administration Infiltration, Nerve Block
Strength 20 mg/mL
Volume 30 mL
Container Fliptop Multiple Dose Vial
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Local anesthesia

Lidocaine Hydrochloride and Epinephrine Injection

Lidocaine Hydrochloride and Epinephrine Injection is a sterile combination of lidocaine, an amide-type local anesthetic, and epinephrine, an alpha and beta adrenergic agonist. Indicated for adult and pediatric patients, it delivers local or regional anesthesia and analgesia across surgical, dental, diagnostic, therapeutic, and obstetrical procedures.

Key Benefits

  • Broad Procedural Coverage: Indicated for infiltration, peripheral nerve blocks, sympathetic nerve blocks, epidural, and caudal anesthesia.
  • Multiple Concentrations and Presentations: Available in 0.5%, 1%, 1.5%, and 2% concentrations in single-dose ampuls, single-dose vials, and multiple-dose vials.
  • Higher Maximum Dose with Epinephrine: The combination allows up to 7 mg/kg (not to exceed 500 mg), versus 4.5 mg/kg (not to exceed 300 mg) for lidocaine alone.
  • Pediatric and Adult Approved: Indicated across a wide range of procedures in both adult and pediatric patients.
  • Epidural Test Dose Capability: The 1.5% concentration with 1:200,000 epinephrine is specifically recommended as a test dose for epidural and caudal blocks to detect unintended intravascular or intrathecal injection.

Dosage and Administration

Dosage is individualized based on the anesthetic procedure, tissue vascularity, required anesthesia depth, and patient condition. Always use the lowest effective concentration and smallest dose producing the desired result.

  • Adult Maximum Dose: Not to exceed 7 mg/kg body weight or 500 mg total.
  • Continuous Epidural/Caudal Anesthesia: Maximum dose intervals must not be less than 90 minutes.
  • Pediatric Dosing (over 3 years): Approximately 3.3 mg/kg to 4.4 mg/kg, adjusted for weight and development.

Why Choose Lidocaine Hydrochloride and Epinephrine Injection?

This combination product delivers local anesthetic action via lidocaine and vasoconstrictive support via epinephrine in a single formulation, supporting infiltration, nerve block, epidural, and caudal block types across multiple concentrations and vial presentations — as described in the prescribing information.

Warnings

  • Dose-Related Toxicity: Cardiovascular and respiratory vital signs and patient consciousness must be monitored after each injection; delays in managing toxicity may lead to acidosis, cardiac arrest, and death.
  • Methemoglobinemia: Cases have been reported with local anesthetic use; patients with G6PD deficiency, infants under 6 months, and those on oxidizing agents are at increased risk of severe outcomes including seizures, arrhythmias, and death.
  • Systemic Toxicity Risk from Unintended Injection: Unintended intravascular or intrathecal injection may cause CNS or cardiorespiratory depression, coma, and respiratory arrest; aspirate prior to each injection and use a test dose for epidural blocks when feasible.

Disclaimer: This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.
Products specifications
Brands in this category
Picture for manufacturer American Regent
Picture for manufacturer Exela
Picture for manufacturer Hospira
Picture for manufacturer McGuff Pharmaceuticals
Picture for manufacturer Mylan

Featured Articles

McGuff’s Promise of Quality and Service

For over 50 years, we’ve been the trusted name in healthcare excellence. Medical practitioners can rely on us for quality products, fast deliveries, and superior service. We strive for customer satisfaction and maintaining that trust.

We at the McGuff Company, Inc. (McGuff) work very hard to provide you accurate and timely information on our website. However, it is your obligation to verify such information before using the products purchased from McGuff.

All information is provided “As-is” and may change without prior notice. McGuff does not make warranty or representation that the information contained on this site is accurate, current, or complete.

Any use of information by you is without recourse to McGuff and is at your own risk.

McGuff is in no way responsible for any damages whether direct, consequential, incidental, or otherwise suffered by you or others on your behalf as a result of using or relying upon such information for any purpose.

Products specifications
Medical License Required Yes
Class Rx Only
Product Name Injection
Generic Name Lidocaine HCl and Epinephrine
Route of Administration Infiltration, Nerve Block
Strength 20 mg/mL
Volume 30 mL
Container Fliptop Multiple Dose Vial
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Local anesthesia

Contact Us

McGuff Company is LegitScript Certified

Copyright © 2026 McGuff Company, Inc. All rights reserved.

For information on the duties and responsibilities of this web site, please read our privacy policy and our warning and disclaimer . Use of this website signifies your agreement to the Privacy Policy and Warning Disclaimer.

Coronavirus (COVID-19)

Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.

In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.

Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.

As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.

Click here for updates regarding Coronavirus Pandemic and Your Supplies and a message from our President